| ā | Relapse | Primary tumor | ā | Site of biopsy | relapse characteristics | Primary tumor characteristics |
| Patient 1 | liver | CDI ER90%, PgR 5%, Mib1 30%, HER2 1+ | CDI ER100%, PgR60%, MIb1 25%, HER2 1+ | Patient 2 | breast | CDI ER60%, PgR 95%, Mib1 10%, HER2 1+ | CDI ER98%, PgR98%, MIb1 15%, HER2 1+ | Patient 3 | liver | CDI ER40%, PgR30%, Mib1 40%, HER2 0 | CDI ER98%, PgR70%, MIb1 30%, HER2 1+ | Patient 4 | liver | CDI ER100%, PgR 50%, Mib1 40%, HER2 1+ | CDI ER100%, PgR80%, MIb1 25%, HER2 1+ | Patient 5 | chest wall | CDI ER 99%, PgR70%, Mib1 15%, HER2 0+ | CDI ER 99%, PgR 70%, MIB1 15%, HER2 1+ | Patient 6 | liver | CDI ER 95%, PgR2%, Mib1 25%, HER2 1+ | CDI ER 85%, PgR 70%, MIB1 35%, HER2 1+ | Patient 7 | lung | CDI ER 85%, PgR25%, Mib1 15%, HER2 1+ | CDI ER 80%, PgR 60%, MIB1 25%, HER2 0+ | Patient 8 | breast | CDI ER 100%, PgR100%, Mib1 30%, HER2 1+ | CDI ER 100%, PgR 100%, MIB1 35%, HER2 1+ | Patient 9 | liver | CDI ER 99%, PgR99%, Mib1 50%, HER2 1+ | CDI ER 80%, PgR 60%, MIB1 25%, HER2 0+ | Patient 10 | liver | CDI ER 90%, PgR60%, Mib1 22%, HER2 1+ | CDI ER 50%, PgR 50%, Mib1 10%, HER2 1+ | Patient 11 | liver | CDI ER 80%, PgR0%, Mib1 40%, HER2 1+ | CDI ER 90%, PgR 50%, MIB1 25%, HER2 1+ | Patient 12 | skin | CDI ER 99%, PgR50%, Mib1 25%, HER2 1+ | not applicable | Patient 13 | bone | CDI ER 70%, PgR0%, Mib1 35%, HER2 0+ | CDI ER 80%, PgR 60%, MIB1 25%, HER2 0+ | Patient 14 | bone | CDI ER 50%, PgR5%, Mib1 25%, HER2 0+ | not applicable | Patient 15 | liver | CDI ER 100%, PgR10%, Mib1 20%, HER2 1+ | not applicable | Patient 16 | lymph node | CDI ER 70%, PgR0%, Mib1 25%, HER2 1+ | CDI ER 90%, PgR 80%, MIB1 8%, HER2 0+ | Patient 17 | liver | CDI ER 95%, PgR80%, Mib1 15%, HER2 0+ | CDI ER 100%, PgR 100%, MIB1 15%, HER2 0+ | Patient 18 | lung | CDI ER 90%, PgR2%, Mib1 30%, HER2 1+ | CDI ER 50%, PgR 65%, MIB1 25%, HER2 0+ | Patient 19 | lung | CDI ER 95%, PgR25%, Mib1 10%, HER2 1+ | CDI ER 60%, PgR 10%, MIB1 25%, HER2 1+ | Patient 20 | lung | CDI ER 75%, PgR50%, Mib1 10%, HER2 1+ | CDI ER 75%, PgR 20%, MIB1 15%, HER2 0+ | Patient 21 | bone | CDI ER 95%, PgR65%, Mib1 25%, HER2 1+ | not applicable | Patient 22 | bone | CDI ER 95%, PgR95%, Mib1 10%, HER2 1+ | CDI ER 100%, PgR 85%, MIB1 3%, HER2 0+ | Patient 23 | liver | CDI ER 90%, PgR25%, Mib1 40%, HER2 0+ | not applicable | Patient 24 | lung | CDI ER 50%, PgR50%, Mib1 30%, HER2 1+ | CDI ER 70%, PgR 50%, MIB1 25%, HER2 1+ | Patient 25 | lymph node | CDI ER 100%, PgR5%, Mib1 15%, HER2 0+ | not applicable |
|
|